OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
JRJCY China Finance Online Co Ltd
FLXS Flexsteel Industries Inc
STAR iStar Inc
DIOD Diodes Inc
NBIX Neurocrine Biosciences Inc
TSLA Tesla Inc
GOOGL Alphabet Inc
AMZN Amazon.com Inc
PHM Pultegroup Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

OraSure Technologies, Inc. (OraSure) develops, manufactures, and distributes of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. OraSure's segments consist of Diagnostics and Molecular Solutions. Diagnostics business segment primarily consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products. The Diagnostics business includes tests for diseases including COVID-19, human immunodeficiency virus (HIV) and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Molecular Solutions business products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Price
Delayed
$5.05
Day's Change
-0.025 (-0.49%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.07
Day's Low
4.96
Volume
(Light)

Today's volume of 98,841 shares is on pace to be much lighter than OSUR's 10-day average volume of 629,693 shares.

98,841

OSUR's position in the Health Care Equipment & Supplies industry

Industry PeersOSURNEOGVIVOCEMI

Summary

Company ProfileOraSure Technologies, Inc. (OraSure) develops, manufactures, and distributes of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. OraSure's...
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety...
Go to NEOG summary
Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain...
Go to VIVO summary
Chembio Diagnostics, Inc. develops and commercializes point-of-care diagnostic tests used for the rapid detection and diagnosis of infectious diseases, including sexually transmitted disease, insect...
Go to CEMI summary
52-Week Change

VS. INDUSTRY
-43.29%
-59.38%
61.94%
-84.33%
Market Cap

VS. INDUSTRY
$368.2M
$3.6B
$1.4B
$11.0M
Beta

VS. INDUSTRY
0.2
0.8
0.3
1.7
Dividend Yield

VS. INDUSTRY
--
--
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
48.67x
33.44x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$328.0M
$531.2M
$333.0M
$59.8M
Profit Margin

VS. INDUSTRY
-13.38%
6.86%
12.75%
-60.93%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
0.88%
13.57%
--
Revenue Growth (TTM)

VS. INDUSTRY
40.78%
8.98%
4.76%
59.46%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.